NO20083276L - Behandling av diabetes med tiazolidindion og sulfonylurea - Google Patents
Behandling av diabetes med tiazolidindion og sulfonylureaInfo
- Publication number
- NO20083276L NO20083276L NO20083276A NO20083276A NO20083276L NO 20083276 L NO20083276 L NO 20083276L NO 20083276 A NO20083276 A NO 20083276A NO 20083276 A NO20083276 A NO 20083276A NO 20083276 L NO20083276 L NO 20083276L
- Authority
- NO
- Norway
- Prior art keywords
- thiazolidinedione
- sulfonylurea
- diabetes
- treatment
- mammal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/145—Amines having sulfur, e.g. thiurams (>N—C(S)—S—C(S)—N< and >N—C(S)—S—S—C(S)—N<), Sulfinylamines (—N=SO), Sulfonylamines (—N=SO2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Det beskrives en fremgangsmåte for behandling av diabetes mellitus og tilstander assosiert med diabetes mellitus hos et pattedyr, som omfatter administrering av en effektiv ugiftig og farmasøytisk godtagbar mengde av en insulinsensibilisator og et insulinutskillende middel, til et pattedyr med behov for dette.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9712854.0A GB9712854D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
GBGB9806710.1A GB9806710D0 (en) | 1998-03-27 | 1998-03-27 | Novel method |
PCT/EP1998/003688 WO1998057649A1 (en) | 1997-06-18 | 1998-06-15 | Treatment of diabetes with thiazolidinedione and sulphonylurea |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20083276L true NO20083276L (no) | 2000-02-17 |
Family
ID=26311744
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19996264A NO326263B1 (no) | 1997-06-18 | 1999-12-17 | Kombinasjon omfattende tiazolidindion og sulfonylurea, anvendelse derav, samt farmasoytisk sammensetning |
NO20083276A NO20083276L (no) | 1997-06-18 | 2008-07-24 | Behandling av diabetes med tiazolidindion og sulfonylurea |
NO2009002C NO2009002I1 (no) | 1997-06-18 | 2009-02-13 | 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19996264A NO326263B1 (no) | 1997-06-18 | 1999-12-17 | Kombinasjon omfattende tiazolidindion og sulfonylurea, anvendelse derav, samt farmasoytisk sammensetning |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2009002C NO2009002I1 (no) | 1997-06-18 | 2009-02-13 | 5-{4-[2-(N-metyl-N-(2-pyridyl)amino)etoksy]benzyl}tiazolidin-2,4-dionmaleat(salter/solvater)+glimepirid |
Country Status (34)
Country | Link |
---|---|
EP (3) | EP1671637A3 (no) |
JP (1) | JP2001523270A (no) |
KR (3) | KR20010013840A (no) |
CN (1) | CN1168451C (no) |
AP (1) | AP1600A (no) |
AR (2) | AR012996A1 (no) |
AT (1) | ATE353654T1 (no) |
AU (1) | AU8539298A (no) |
BG (2) | BG64817B1 (no) |
BR (1) | BR9810142A (no) |
CA (1) | CA2294385C (no) |
CO (1) | CO4940457A1 (no) |
CZ (1) | CZ299310B6 (no) |
DE (1) | DE69837089T2 (no) |
DZ (1) | DZ2522A1 (no) |
EA (1) | EA003025B1 (no) |
ES (1) | ES2283064T3 (no) |
HK (1) | HK1028200A1 (no) |
ID (1) | ID24065A (no) |
IL (1) | IL133137A (no) |
IN (1) | IN189319B (no) |
MA (1) | MA24571A1 (no) |
MY (1) | MY125855A (no) |
NO (3) | NO326263B1 (no) |
NZ (1) | NZ501163A (no) |
OA (1) | OA11510A (no) |
PE (1) | PE108199A1 (no) |
PL (2) | PL337510A1 (no) |
SK (1) | SK286028B6 (no) |
TR (1) | TR199903096T2 (no) |
TW (1) | TW542717B (no) |
UA (1) | UA67743C2 (no) |
UY (1) | UY25048A1 (no) |
WO (1) | WO1998057649A1 (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
PT1173434E (pt) | 1999-04-23 | 2003-12-31 | Smithkline Beecham Plc | Novo produto farmaceutico |
AU1452601A (en) | 1999-11-01 | 2001-05-14 | Wisconsin Alumni Research Foundation | Cholesterol transport gene |
US7964216B2 (en) | 2001-01-12 | 2011-06-21 | Sun Pharma Advanced Research Company Limited | Spaced drug delivery system |
KR100698595B1 (ko) * | 2003-09-29 | 2007-03-21 | 보령제약 주식회사 | 무정형 또는 준결정형 글리메피리드, 이의 제조방법 및 무정형 또는 준결정형 글리메피리드를 포함하는 약학적조성물 |
RU2359661C2 (ru) * | 2003-10-31 | 2009-06-27 | Такеда Фармасьютикал Компани Лимитед | Твердый препарат |
NZ569071A (en) | 2005-12-22 | 2011-01-28 | Takeda Pharmaceutical | Solid preparation containing an insulin sensitizer |
CN104158867B (zh) * | 2014-08-06 | 2017-05-17 | 电子科技大学 | 一种基于wave协议的信息多跳转发方法 |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS5697277A (en) | 1980-01-07 | 1981-08-05 | Takeda Chem Ind Ltd | Thiazolidine derivative |
JPS6051189A (ja) | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
US4582839A (en) | 1984-03-21 | 1986-04-15 | Takeda Chemical Industries, Ltd. | 2,4-thiazolidinediones |
CN1003445B (zh) | 1984-10-03 | 1989-03-01 | 武田药品工业株式会社 | 噻唑烷二酮衍生物,其制备方法和用途 |
DK173350B1 (da) | 1985-02-26 | 2000-08-07 | Sankyo Co | Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem |
JPH06779B2 (ja) | 1985-06-10 | 1994-01-05 | 武田薬品工業株式会社 | チアゾリジオン誘導体およびそれを含んでなる医薬組成物 |
US4812570A (en) | 1986-07-24 | 1989-03-14 | Takeda Chemical Industries, Ltd. | Method for producing thiazolidinedione derivatives |
ATE186724T1 (de) * | 1987-09-04 | 1999-12-15 | Beecham Group Plc | Substituierte thiazolidindionderivate |
US4791125A (en) | 1987-12-02 | 1988-12-13 | Pfizer Inc. | Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents |
US5061717A (en) | 1988-03-08 | 1991-10-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
MX15171A (es) | 1988-03-08 | 1993-05-01 | Pfizer | Derivados de tiazolidinodiona hipoglicemicos |
WO1991007107A1 (en) | 1989-11-13 | 1991-05-30 | Pfizer Inc. | Oxazolidinedione hypoglycemic agents |
US5089514A (en) | 1990-06-14 | 1992-02-18 | Pfizer Inc. | 3-coxazolyl [phenyl, chromanyl or benzofuranyl]-2-hydroxypropionic acid derivatives and analogs as hypoglycemic agents |
KR930701436A (ko) | 1990-07-03 | 1993-06-11 | 오노다 마사아이 | 비스헤테로환 화합물 |
JPH0678326B2 (ja) | 1990-08-23 | 1994-10-05 | フアイザー・インコーポレイテツド | 血糖低下性ヒドロキシ尿素誘導体 |
JPH04210683A (ja) | 1990-12-06 | 1992-07-31 | Terumo Corp | チアゾリジン−2,4−ジオン誘導体およびこれを含有する糖尿病合併症治療薬 |
US5183823A (en) | 1991-04-11 | 1993-02-02 | Takeda Chemical Industries, Ltd. | Pyridine n-oxide compounds which are useful as hypoglycemic and hypolipidemic agents |
CZ196693A3 (en) | 1991-04-11 | 1994-05-18 | Upjohn Co | Thiazolidinedione derivatives, and process for preparing thereof |
TW222626B (no) | 1991-07-22 | 1994-04-21 | Pfizer | |
FR2680512B1 (fr) | 1991-08-20 | 1995-01-20 | Adir | Nouveaux derives de 2,4-thiazolidinedione, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
JPH06510286A (ja) * | 1991-08-26 | 1994-11-17 | ファルマシア・アンド・アップジョン・カンパニー | 3−グアニジノプロピオン酸およびピオグリタゾン、グリベンクラミドまたはグリメピリドを含有する医薬組成物 |
JPH05271204A (ja) | 1992-03-26 | 1993-10-19 | Japan Tobacco Inc | 新規なトリアジン誘導体 |
US5264451A (en) | 1992-04-07 | 1993-11-23 | American Home Products Corporation | Process for treating hyperglycemia using trifluoromethyl substituted 3H-pyrazol-3-ones |
AU3959193A (en) | 1992-04-10 | 1993-11-18 | Smithkline Beecham Plc | Heterocyclic compounds and their use in the treatment of type II-diabetes |
WO1993022445A1 (en) | 1992-05-05 | 1993-11-11 | The Upjohn Company | A process for producing pioglitazone metabolite |
NZ253742A (en) | 1992-07-03 | 1997-06-24 | Smithkline Beecham Plc | Heterocyclylaminoalkoxy substituted phenyl derivatives and pharmaceutical compositions |
US5232945A (en) | 1992-07-20 | 1993-08-03 | Pfizer Inc. | 3-aryl-2-hydroxypropionic acid derivatives and analogs as antihypertensives |
GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
US5457109A (en) | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
TW438587B (en) * | 1995-06-20 | 2001-06-07 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
-
1998
- 1998-06-15 PL PL98337510A patent/PL337510A1/xx not_active Application Discontinuation
- 1998-06-15 PL PL377979A patent/PL198018B1/pl not_active IP Right Cessation
- 1998-06-15 CZ CZ0457799A patent/CZ299310B6/cs not_active IP Right Cessation
- 1998-06-15 AT AT98936363T patent/ATE353654T1/de not_active IP Right Cessation
- 1998-06-15 AU AU85392/98A patent/AU8539298A/en not_active Abandoned
- 1998-06-15 NZ NZ501163A patent/NZ501163A/en unknown
- 1998-06-15 TR TR1999/03096T patent/TR199903096T2/xx unknown
- 1998-06-15 WO PCT/EP1998/003688 patent/WO1998057649A1/en active IP Right Grant
- 1998-06-15 KR KR1019997011861A patent/KR20010013840A/ko not_active Application Discontinuation
- 1998-06-15 KR KR1020087001560A patent/KR20080011356A/ko not_active Application Discontinuation
- 1998-06-15 AP APAP/P/1999/001717A patent/AP1600A/en active
- 1998-06-15 JP JP50375499A patent/JP2001523270A/ja active Pending
- 1998-06-15 EP EP06075523A patent/EP1671637A3/en not_active Ceased
- 1998-06-15 EP EP98936363A patent/EP0999845B1/en not_active Expired - Lifetime
- 1998-06-15 ES ES98936363T patent/ES2283064T3/es not_active Expired - Lifetime
- 1998-06-15 SK SK1791-99A patent/SK286028B6/sk not_active IP Right Cessation
- 1998-06-15 EA EA200000039A patent/EA003025B1/ru not_active IP Right Cessation
- 1998-06-15 CN CNB988061880A patent/CN1168451C/zh not_active Expired - Fee Related
- 1998-06-15 CA CA002294385A patent/CA2294385C/en not_active Expired - Fee Related
- 1998-06-15 DE DE69837089T patent/DE69837089T2/de not_active Expired - Lifetime
- 1998-06-15 UA UA99126878A patent/UA67743C2/uk unknown
- 1998-06-15 IL IL13313798A patent/IL133137A/en not_active IP Right Cessation
- 1998-06-15 KR KR1020077000227A patent/KR20070011651A/ko not_active Application Discontinuation
- 1998-06-15 EP EP10176770A patent/EP2266576A1/en not_active Withdrawn
- 1998-06-15 ID IDW991628A patent/ID24065A/id unknown
- 1998-06-15 BR BR9810142-0A patent/BR9810142A/pt not_active Application Discontinuation
- 1998-06-17 AR ARP980102881A patent/AR012996A1/es unknown
- 1998-06-17 MY MYPI98002709A patent/MY125855A/en unknown
- 1998-06-17 AR ARP980102879A patent/AR008025A1/es not_active Application Discontinuation
- 1998-06-17 MA MA25120A patent/MA24571A1/fr unknown
- 1998-06-17 TW TW087109616A patent/TW542717B/zh not_active IP Right Cessation
- 1998-06-17 DZ DZ980132A patent/DZ2522A1/xx active
- 1998-06-18 IN IN1692DE1998 patent/IN189319B/en unknown
- 1998-06-18 UY UY25048A patent/UY25048A1/es not_active Application Discontinuation
- 1998-06-18 CO CO98034645A patent/CO4940457A1/es unknown
- 1998-06-18 PE PE1998000532A patent/PE108199A1/es not_active Application Discontinuation
-
1999
- 1999-12-17 OA OA9900293A patent/OA11510A/en unknown
- 1999-12-17 NO NO19996264A patent/NO326263B1/no not_active IP Right Cessation
-
2000
- 2000-01-06 BG BG104058A patent/BG64817B1/bg unknown
- 2000-01-06 BG BG109397A patent/BG109397A/bg unknown
- 2000-10-30 HK HK00106909A patent/HK1028200A1/xx not_active IP Right Cessation
-
2008
- 2008-07-24 NO NO20083276A patent/NO20083276L/no not_active Application Discontinuation
-
2009
- 2009-02-13 NO NO2009002C patent/NO2009002I1/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20083276L (no) | Behandling av diabetes med tiazolidindion og sulfonylurea | |
NO20090846L (no) | Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav | |
LU92615I2 (fr) | Alogliptin et ses dérivés pharmaceutiquement acceptables (VIPIDIA) | |
ATE372782T1 (de) | Synergitische verwendung von thiazolidinedionen und glucagon-ähnlichem peptid-1 und dessen agonisten für die behandlung von nicht-insulin- abhängigen diabetes | |
HK153996A (en) | Use of insulin sensitizing agents to treat hypertension | |
EA200000747A1 (ru) | СПОСОБ ВВЕДЕНИЯ AspB28-ИНСУЛИНА ЧЕЛОВЕКА | |
DK1572230T3 (da) | Placenta alkalisk phosphatase til at kontrollere diabetes | |
MY155219A (en) | Treatment of diabetes with thiazolidinedione, insulin secretagogue and biguanide | |
NO992062L (no) | Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel | |
HUP0003260A2 (hu) | Gyógyszerkészítmény diabetes kezelésére rosziglitazonnal és inzulinnal | |
NO996270L (no) | Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor | |
NO20000230L (no) | Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor | |
EA200000141A1 (ru) | Способ лечения диабета тиазолидиндионом и сульфонилмочевиной | |
TR200000957T2 (tr) | Hiperglisemi tedavisinde tiazolidinedion kullanımı | |
RU94010369A (ru) | Способ получения производных инсулина | |
ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
HUP0002668A2 (hu) | Diabetes kezelésére dioxo-tiazolidinnel és metforminnal | |
HUP0002669A2 (hu) | Diabetes kezelése dioxo-tiazolidinnel és szulfonil-karbamiddal | |
RU96115219A (ru) | Способ лечения больных сахарным диабетом | |
HUP0002569A2 (hu) | Diabetes kezelésére alkalmas dioxo-tiazolidint és alfa-glükozidáz inhibitort tartalmazó gyógyszerkészítmények | |
NZ503862A (en) | Use of insulin sensitisers (especially thiazolidinediones) for the treatment of hyperglycaemia | |
ECSP982535A (es) | Nuevo metodo de tratamiento (i) | |
NZ273710A (en) | use of ketoconazole or a derivative which is a cortisol synthesis inhibitor in medicaments for treatment of type II diabetes | |
UA23882A (uk) | Спосіб лікування виразкової хвороби дванадцятипало ї кишки | |
ECSP982591A (es) | Nuevo metodo de tratamiento iv |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |